TO GET ENOUGH SLEEP AND
REGULAR EXERCISE.
ALSO, ON THE HEALTHWATCH
TONIGHT AN UPDATE FOR YOU, THE
F.D.A. TODAY APPROVED THE
NATION'S FIRST GENE THERAPY
FOR AN INHERITED DISEASE.
IT IS MADE BY SPARK
THERAPEUTICS BASED HERE IN
PHILADELPHIA WE HAVE BEEN
FOLLOWING DEVELOPMENT OF THE
TREATMENT THAT IMPROVES VISION
FOR PATIENTS WITH A RARE FORM
OF BLINDNESS.
THE ONE TIME INJECTION CALLS
LOCKSEARNNA RESTORES SIGHT BY
REPLACING THE DEFECTIVE GENE.
IT IS EXPECT TO COST AROUND A
HALF MILLION-DOLLAR PER EYE,
